Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call reveals strong financial performance across multiple segments, with record high revenues in sectors like AI and industrials. The management's guidance is optimistic, expecting improved margins and a stronger second half of the year. Despite negative free cash flow due to capacity expansion, the strategic focus on growth and customer expansion in AI is promising. The Q&A session supports this positive outlook, highlighting corrected inefficiencies and expanding AI customer base with major tech companies. Given the market cap, the stock is likely to react positively, with a projected increase of 2% to 8%.
Revenue Revenue grew sequentially 7% to $762 million, in line with guidance. Compared to the second quarter of 2024, revenues increased 3%, reflecting a 3% increase in volume, 2% positive foreign currency impact, and a 2% reduction in ASPs, including tariff adders.
Automotive Revenue Automotive revenue increased 4% versus the quarter due to improved demand from Tier 1 customers, modest increase in consignment pulls in the Americas, new ADAS programs in Europe, and higher volumes in Asia.
Industrial Revenue Revenue from the Industrial segment increased 9% from the first quarter, driven by normalization of customer and channel inventories, strengthening demand for smart grid infrastructure, AI chip production, and data center projects.
Aerospace/Defense Revenue Revenue increased 5% quarter-over-quarter due to improved demand for military applications, while commercial aerospace declined due to mechanical parts supply issues in Europe.
Medical Revenue Revenue grew 4%, reflecting stronger demand in implantables and measurement equipment, with design activity focused on defibrillators, surgical assistant systems, drug delivery, diagnostic equipment, and hearing aid implants.
Other Segments Revenue (Computer, Consumer, Telecom) Revenue was up 9% for the sixth consecutive quarter of sequential growth, driven by escalating demand related to AI servers and server power in Asia.
Gross Profit and Margin Gross profit was $149 million, resulting in a gross margin of 19.5%, at the high end of guidance. The increase from quarter 1 was primarily due to additional volume.
SG&A Expenses SG&A expenses were $127 million, including an $11 million benefit recognized upon the one-time favorable resolution of an outstanding matter. Excluding this, SG&A expenses would have been in the range of guidance.
EBITDA EBITDA for the quarter was $75 million for an EBITDA margin of 9.8%. Adjusted EBITDA for the quarter was $64 million for an adjusted EBITDA margin of 8.3%, up from 7.6% in the first quarter.
Cash Flow Used $9 million of operating cash in the second quarter, with free cash flow for the quarter being negative $73 million compared to negative $45 million in the first quarter. This was due to capacity expansion projects and tax payments.
Revenue growth: Revenue grew sequentially 7% to $762 million, driven by growth in semiconductors, passives, and all end markets.
Capacity expansion: Invested approximately $775 million over 2.5 years to expand capacity for high-growth, higher-profit products.
AI and power applications: Strong demand for AI power applications and smart grid infrastructure projects.
Silicon carbide strategy: Advancing silicon carbide strategy with new product releases and preproduction scheduled for early 2026.
Automotive market: Revenue increased 4% due to demand for ADAS programs, battery electric vehicles, and hybrid powertrains.
Industrial market: Revenue increased 9%, driven by smart grid infrastructure projects and AI chip production.
Aerospace/Defense market: Revenue increased 5%, with strong demand for military applications and low earth orbit satellites.
Medical market: Revenue grew 4%, driven by demand for implantables and diagnostic equipment.
Inventory normalization: Inventory correction cycle is behind, with normalized levels for passives and improving for semiconductors.
Distributor engagement: Distribution revenue grew 11%, supported by SKU count expansion and faster consumption rates.
Geographical performance: Revenue grew in all regions, led by Asia with a 12% increase.
Vishay 3.0 strategic plan: Executing a 5-year plan to drive revenue growth, profitability, and capital returns.
Subcontractor initiative: Added 5 subcontractors and qualified over 8,000 part numbers to expand product portfolio.
Technology advancements: Progress in silicon carbide, MOSFETs, and diode technologies to support automotive and industrial applications.
Inventory Correction Cycle: While the inventory correction cycle for passives is behind, there is still some excess industry inventory in semiconductors, which could impact future sales and production efficiency.
Customer Program Adjustments: Semiconductors experienced a slight dip in book-to-bill ratio due to customer program adjustments, indicating potential volatility in demand.
Supply Chain and Production Delays: Technical issues at the SK Keyfoundry in Korea have delayed the release of certain technologies by 1-2 quarters, potentially impacting the timeline for increasing MOSFET capacity.
Commercial Aerospace Decline: Ongoing mechanical parts supply issues in Europe have led to a decline in commercial aerospace revenue, which could affect overall performance in this segment.
Factory Automation Demand: Demand for factory automation projects remains flat in the Americas and Europe, reflecting slow capital investment by companies.
Tariff and Input Costs: Higher input costs and tariffs are expected to impact gross margins, with tariffs being passed on to customers but still influencing revenue and profitability.
Cash Flow and Liquidity: Negative free cash flow due to capacity expansion plans and reliance on U.S.-based liquidity could strain financial flexibility, especially with ongoing investments and dividend commitments.
Customer Audits and Qualifications: Delays in customer audits and qualifications for new facilities and products, such as in Mexico and Newport, could slow down the ramp-up of production and sales.
Geopolitical and Regional Risks: Regional EMS inventory adjustments in Europe and tariff-related pauses in Asia could create uneven revenue growth across geographies.
Economic Sensitivity: Slow recovery in certain sectors, such as factory automation and commercial aerospace, highlights sensitivity to broader economic conditions.
Revenue Expectations: For the third quarter of 2025, revenues are expected to be $775 million, plus or minus $20 million, representing a 2% volume increase and reflecting some seasonality in Europe.
Gross Margin Projections: Gross margin is expected to be in the range of 19.7%, plus or minus 50 basis points, inclusive of tariff impacts and expected higher input costs. Newport is expected to have an approximate 160 to 185 basis point drag on the margin in the third quarter.
Capital Expenditures: For 2025, the company plans to spend between $300 million to $350 million, at least 70% of which will be invested in capital expansion projects for high-growth product lines.
Silicon Carbide Preproduction: The Newport wafer fab remains on schedule for silicon carbide preproduction in early 2026.
MOSFET Capacity Expansion: The company expects to meet its goal of increasing the annualized capacity for MOSFETs by 12% in the first quarter of 2026 and to increase annualized capacity for advanced split-gate MOSFETs by 25% to support new automotive and commercial opportunities in 2026.
Silicon Carbide Product Releases: By year-end 2025, the company plans to release an additional 16 Gen 2 1,200-volt MOSFETs for automotive and industrial applications. The 1,700-volt planar MOSFET and the 650-volt planar MOSFET are expected to be released in the first quarter of 2026. Samples of the 1,200-volt trench MOSFET are expected to be available in the third quarter of 2025, with a market release in the fourth quarter of 2025.
Silicon Carbide Diodes: The company plans to release the entire silicon carbide Gen 4 diode family with all current ratings and power packages in the second half of 2025.
Market Trends and Demand: The company is preparing for a stronger second half of 2025 compared to the first half, with backlog building in both semis and passives. Market indicators are directionally positive, signaling a potential market upturn.
Quarterly Dividend: $13.6 million was distributed as a quarterly dividend in the second quarter of 2025.
Share Repurchase: No shares were repurchased in the second quarter of 2025.
Stockholder Return Policy: The company plans to return at least 70% of free cash to stockholders in the form of dividends and stock repurchases. However, due to negative free cash flow expected in 2025, share repurchases will be opportunistic and based on U.S. available liquidity.
The earnings call presents a mixed picture. While there are positive aspects like strong demand in AI-related applications and stable revenue in healthcare, there are concerns about rising SG&A expenses and declining EBITDA margin. The Q&A reveals cautious optimism with mid-single-digit growth expectations and price adjustments to counter cost pressures. However, uncertainties around share gains, M&A, and memory pricing impact add ambiguity. Given the company's market cap and the balanced positives and negatives, the stock price is likely to remain neutral, with limited short-term movement.
The earnings call presented mixed signals: revenue and EBITDA improved, but gross margins and book-to-bill ratios were slightly concerning. The Q&A highlighted management's uncertainty on key issues like export restrictions and margin impacts, while also noting no share buybacks due to liquidity constraints. However, the positive revenue growth and margin expansion outlook for 2025, along with improved cash flow, provide a balanced view. Considering the market cap, the stock is likely to experience minimal movement, resulting in a neutral sentiment prediction.
The earnings call reveals strong financial performance across multiple segments, with record high revenues in sectors like AI and industrials. The management's guidance is optimistic, expecting improved margins and a stronger second half of the year. Despite negative free cash flow due to capacity expansion, the strategic focus on growth and customer expansion in AI is promising. The Q&A session supports this positive outlook, highlighting corrected inefficiencies and expanding AI customer base with major tech companies. Given the market cap, the stock is likely to react positively, with a projected increase of 2% to 8%.
The earnings call presented a mix of positive and negative indicators. While the book-to-bill ratio and stockholder returns are positive, revenue and gross profit declines, alongside unclear guidance on AI business size, are concerning. The Q&A session highlighted some optimism for future quarters, but economic uncertainties and flat revenue in key regions temper expectations. With a market cap over $3 billion, the stock's movement is likely to be less volatile. Overall, the sentiment is neutral, with a potential range of -2% to 2% over the next two weeks.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.